Essential Premium

Biopharma Funds Deliver Market-Beating Returns as Valuations Snap Back

With blockbuster gains in 2025 and Wall Street asserting that investors overreacted to government cuts at the FDA, hedge funds focused on life sciences are emerging as some of the industry’s biggest winners.

Qatari Family Office Al Faisal Holding Charts New Course Beyond Real Estate

The Al Thani-linked conglomerate is tilting toward tech, healthcare, and energy partnerships as Qatar ramps up economic diversification under its National Vision 2030.

Sponsored

The Historical Benefits of US Private Real Estate

Tulip Trend and Quantedge Lead November Gains for CTAs

A handful of managed futures funds posted standout returns last month, with Tulip surging 8 percent and Quantedge cementing double-digit gains for the year.

Related Content

Casdin Leads Life Sciences Funds in a Recovery Year

Steve Taub

Sosin Partners Takes Profits on Carvana After Turning Crisis Into Windfall

Stephen Taub

Coatue Joins $2.3 Billion Bet on Hot AI Coding Platform

Stephen Taub

1270 Avenue of the Americas, Suite 1100

New York, NY 10020

 

© Institutional Investor, LLC. All material subject to strictly enforced copyright laws. Please read our Terms and Conditions and Privacy Policy before using the site. Institutional Investor is part of Delinian.

 

| Unsubscribe

LinkedIn
X (Twitter)
Bluesky
Instagram